CME’s Rating Lowered Over OTC Growth
Standard & Poor’s has downgraded CME Group from AA to AA- because of an increase in its financial and credit risk profile as a result of “sudden growth” in over-the-counter clearing and increased protection for customers following the bankruptcy of MF Global.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
